<?xml version='1.0' encoding='utf-8'?>
<document id="22794498"><sentence text="Discovery of indole tetrafluorophenoxymethylketone-based potent novel small molecule inhibitors of caspase-3."><entity charOffset="13-50" id="DDI-PubMed.22794498.s1.e0" text="indole tetrafluorophenoxymethylketone" /></sentence><sentence text="" /><sentence text="Caspase-3 inhibition has been demonstrated to be therapeutically effective in moderating excessive programmed cell death" /><sentence text=" Interest in caspase-3 as a therapeutic target has led many to pursue the development of inhibitors" /><sentence text=" To date, only a few series of non-peptide inhibitors have been described, and these have limitations on their drug-like properties" /><sentence text="" /><sentence text="Here, we report the screening of 70 novel small molecules against the caspase-3 enzyme which belongs to four different series (indole fluoromethylketone, indole difluoro and tetrafluorophenoxymethylketone, and oxalamide)"><entity charOffset="154-169" id="DDI-PubMed.22794498.s7.e0" text="indole difluoro" /><entity charOffset="174-204" id="DDI-PubMed.22794498.s7.e1" text="tetrafluorophenoxymethylketone" /><entity charOffset="210-219" id="DDI-PubMed.22794498.s7.e2" text="oxalamide" /><pair ddi="false" e1="DDI-PubMed.22794498.s7.e0" e2="DDI-PubMed.22794498.s7.e0" /><pair ddi="false" e1="DDI-PubMed.22794498.s7.e0" e2="DDI-PubMed.22794498.s7.e1" /><pair ddi="false" e1="DDI-PubMed.22794498.s7.e0" e2="DDI-PubMed.22794498.s7.e2" /><pair ddi="false" e1="DDI-PubMed.22794498.s7.e1" e2="DDI-PubMed.22794498.s7.e1" /><pair ddi="false" e1="DDI-PubMed.22794498.s7.e1" e2="DDI-PubMed.22794498.s7.e2" /></sentence><sentence text=" Selected molecules were subjected for counter-screening, cell-based, ADME/PK assays in order to understand the potency and drug-like properties" /><sentence text="" /><sentence text="The screening yielded series of hits with IC50 values ranging from 0" /><sentence text="11 to 10 Î¼M with reasonable SAR, irreversible mode of inhibition, and reasonable selectivity against other proteases including caspase-1, cathepsin B and D, and thrombin" /><sentence text=" On the basis of in vitro profile, the selected molecules were evaluated for their drug-like properties" /><sentence text=" Among the compounds evaluated, compound 3D exhibited good solubility, low permeability, interaction with efflux pump, and low potential for CYP450 drug-drug interaction" /><sentence text=" After intravenous administration, compound 3D showed low clearance (588 ml/hr/kg), medium volume of distribution, and good oral bioavailability (90%)" /><sentence text="" /><sentence text="These results support further advancement of compound 3D in different apoptotic models to develop as a new anti-apoptotic agent in relevant disease conditions" /><sentence text="" /></document>